Clinical Trial Update: A Study of TAK-441 in Adult Patients With Advanced Nonhematologic Malignancies [Phase 1]

View source ↗

Summary

Phase 1 study of TAK-441 in adults with advanced nonhematologic malignancies has completed. The trial included patients with basal cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Drugs mentioned

• TAK-441

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Advanced Nonhematologic Malignancies, Carcinoma, Basal Cell | Phase 1 | Status: COMPLETED